sharecast

{{ storiesRelated.title }}

Fidelity Top Stories
11 Jun
opec dl oil brent wti crude commodities
OPEC keeps global oil demand forecasts unchanged

The Organisation of the Petroleum Exporting Countries kept its short-term global oil demand forecasts unchanged.

11 Jun
Senior wins $80m parts contracts from Collins Aerospace

Aircraft and defence engineering specialist Senior said it had won 10-year production contracts worth $80m from Collins Aerospace to supply thrust reverser structural components for Boeing 787, Airbus A320neo and Airbus A220 aircraft.

10 Jun
dl chemring defence uk countermeasures control room ftse 250 min
Chemring signs deal with Northrop Grumman for missile material

Chemring said it had signed a 15-year deal partnering deal with US defence firm Northrop Grumman for the supply of HMX energetic material used in its missile programmes along with an order for the product worth $83m as demand for military weapons increased globally.

07 Jun
C&C shares slump as CEO steps down after accounting errors

C&C Group shares plunged on Friday after the drinks maker said chief executive Patrick McMahon would be stepping down after accounting errors in the last three years when he was chief finance director.

06 Jun
dl mitie group outsourcing services engineering care custody outsourcer van logo ftse 250
Mitie revenues hit record £4.5bn on contract wins

Annual profits at outsourcing giant Mitie surged as revenues hit a record £4. 5bn – in line with company expectations laid out in April's trading update.

05 Jun
dl india
Modi loses majority in India election, but will still form govt

Narendra Modi’s ruling Bharatiya Janata Party has lost its parliamentary majority in India's general election, leaving the prime minister to negotiate with regional coalition partners in order to form a government.

03 Jun
zantaccb22
GSK shares slump as US judge says experts can testify in Zantac cases

GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.